BOCCACCIO, Carla
 Distribuzione geografica
Continente #
NA - Nord America 4.367
EU - Europa 2.617
AS - Asia 2.038
OC - Oceania 38
AF - Africa 17
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.096
Nazione #
US - Stati Uniti d'America 4.283
CN - Cina 1.174
IT - Italia 759
SG - Singapore 282
DE - Germania 281
IE - Irlanda 255
SE - Svezia 236
GB - Regno Unito 181
FR - Francia 178
FI - Finlandia 172
UA - Ucraina 151
JP - Giappone 147
KR - Corea 127
CA - Canada 66
NL - Olanda 66
IN - India 63
PL - Polonia 62
ES - Italia 55
HK - Hong Kong 49
BE - Belgio 47
CH - Svizzera 42
ID - Indonesia 38
AU - Australia 34
TW - Taiwan 34
VN - Vietnam 30
RU - Federazione Russa 23
AT - Austria 20
IR - Iran 16
TH - Thailandia 14
DK - Danimarca 13
IL - Israele 13
TR - Turchia 13
MX - Messico 11
NO - Norvegia 11
RO - Romania 11
BR - Brasile 10
MY - Malesia 10
CZ - Repubblica Ceca 9
GR - Grecia 8
PT - Portogallo 6
RS - Serbia 6
DZ - Algeria 5
HU - Ungheria 5
IQ - Iraq 5
PE - Perù 5
JO - Giordania 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SN - Senegal 4
EG - Egitto 3
LT - Lituania 3
LU - Lussemburgo 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
EE - Estonia 2
EU - Europa 2
GL - Groenlandia 2
LK - Sri Lanka 2
MA - Marocco 2
PH - Filippine 2
SA - Arabia Saudita 2
SI - Slovenia 2
AR - Argentina 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 9.096
Città #
Chandler 542
Ann Arbor 391
Santa Clara 349
Beijing 299
Dublin 245
Singapore 230
Fairfield 186
Ashburn 179
Shanghai 151
Houston 149
Dearborn 108
Redwood City 106
Torino 100
Turin 97
Wilmington 95
Jacksonville 90
Milan 90
Princeton 87
Woodbridge 86
Seattle 80
Villeurbanne 80
Medford 77
Columbus 73
Guangzhou 64
Cambridge 58
New York 58
Nyköping 57
Warsaw 54
Tokyo 49
Nanjing 45
Boston 40
Wuhan 39
Helsinki 36
Pisa 36
Hangzhou 35
Rome 34
Jakarta 30
Boardman 29
Chengdu 26
Fremont 25
Brussels 23
Dong Ket 22
Changsha 21
Hefei 21
Paris 20
Verona 20
Vienna 20
San Diego 19
London 18
Chicago 17
Ottawa 16
Shenyang 16
Genoa 15
Los Angeles 15
Luni 15
Naples 15
Zhengzhou 15
Jinan 14
Lappeenranta 14
Madrid 14
Taipei 14
Toronto 14
Falls Church 13
Xian 13
Cossato 12
Munich 12
Osaka 12
Seoul 12
Utrecht 12
Zurich 12
Amsterdam 11
Barcelona 10
Florence 10
Norwalk 10
Shenzhen 10
Washington 10
Catania 9
Hebei 9
Melbourne 9
San Jose 9
Tainan City 9
Carrara 8
Chongqing 8
Duncan 8
Frankfurt am Main 8
Fuzhou 8
Hong Kong 8
Lachine 8
Manchester 8
Stockholm 8
Suzhou 8
Tianjin 8
Bangkok 7
Bern 7
Edinburgh 7
Kunming 7
Mumbai 7
Nashville 7
Padova 7
Phoenix 7
Totale 5.331
Nome #
Known and novel roles of the MET oncogene in cancer: A coherent approach to targeted therapy 1.590
Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer 772
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer 341
Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer. 323
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 260
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype 246
The MET oncogene is a functional marker of a glioblastoma stem cell subtype. 222
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. 190
A molecularly annotated model of patient-derived colon cancer stem-like cells to assess genetic and non-genetic mechanisms of resistance to anti-EGFR therapy 182
TNF-α promotes invasive growth through the MET signaling pathway. 162
Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. 162
MET-Mediated Resistance to EGFR Inhibitors: An Old Liaison Rooted in Colorectal Cancer Stem Cells. 159
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells 149
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 144
A differentiation switch for genetically modified hepatocytes. 132
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 129
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. 125
The MET Oncogene in Glioblastoma Stem Cells: Implications as a Diagnostic Marker and a Therapeutic Target. 122
WHEN REGULATION FAILS: HOW CANCER ARISES 113
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity 107
Cancer and blood coagulation 105
A simplified integrated molecular and immunohistochemistry-based algorithm allows high accuracy prediction of glioblastoma transcriptional subtypes 96
Apoptosis enhancement by the HIV-1 Nef protein. 94
Ionizing radiation fosters cancer invasion through transcriptional up-regulation of the MET oncogene 92
Exploring the interplay between MET and Tumor Necrosis Factor alpha 92
A functional role for hemostasis in early cancer development 90
Ets up-regulates MET transcription 89
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro 89
ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma 89
The MET oncogene drives a genetic programme linking cancer to haemostasis 88
I recettori per i fattori di crescita 86
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. 85
A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor 83
“Metastatic Cancer of Unknown Primary” or “Primary Metastatic Cancer”? 83
I RECETTORI PER I FATTORI DI CRESCITA 80
Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. 80
Derivation and charaterization of cancer initialling cells representative of metastatic colorectal cancer genetic heterogeneity 78
I RECETTORI PER I FATTORI DI CRESCITA 75
Fibroblast nemosis arrests growth and induces differentiation of human leukemia cells 75
Hepatocyte growth factor is a regulator of monocyte-macrophage function 75
Colorectal cancer stem cells, MET and metastasis 75
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 75
I FATTORI DI CRESCITA CONTROLLANO LA PROLIFERAZIONE CELLULARE 73
Invasive growth: a MET-driven genetic programme for cancer and stem cells 73
ERBB3 as a therapeutic target in glioblastoma: overexpression can make the difference 71
The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1. 70
Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. 69
Ligand-independent tyrosine phosphorylation of the receptor encoded by the c-neu oncogene. 68
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells 65
Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients’ management: Close to the clinic? 65
Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth. 61
The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth 61
The MET oncogene drives a genetic programme for stem and cancer cells 60
L'oncogene MET e la cescita invasiva delle cellule staminali del cancro 60
Genetic link between cancer and thrombosis 60
Scatter factors and invasive growth. 58
The HGF receptor family: unconventional signal transducers for invasive cell growth. 57
Interactions between growth factor receptors and adhesion molecules: breaking the rules. 56
GROWTH FACTORS AND CELL SIGNALLING 55
Growth Factor Receptors 52
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 50
Scatter factor-dependent branching morphogenesis: structural and histological features 50
L'oncogene MET regola programmi cellulari che legano il cancro all'emostasi 50
MET, a driver of invasive growth and cancer clonal evolution under therapeutic pressure. 50
Oncogenes, cancer, and haemostasis 49
I recettori per i fattori di crescita 49
QUANDO FALLISCE LA REGOLAZIONE: L'INSORGENZA DEL CANCRO 48
Scatter factors in tumor progression 46
Hepatocyte Growth Factor: A marker and a player in disseminated intravascular coagulation 44
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 36
The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor 34
MET∆14 promotes a ligand-dependent, AKT-driven invasive growth 32
Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary 27
Protocol for in vitro establishment of heterogeneous stem-like cultures derived from whole human glioblastoma tumors 23
Correction to: Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 23
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis 17
An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition 16
null 15
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 12
Totale 9.309
Categoria #
all - tutte 25.493
article - articoli 0
book - libri 0
conference - conferenze 1.632
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020756 0 0 0 0 0 172 158 86 105 117 72 46
2020/20211.156 85 67 97 79 111 66 115 55 132 105 102 142
2021/20221.405 100 111 100 103 102 71 103 92 81 69 251 222
2022/20231.804 176 121 80 161 153 341 156 151 194 46 140 85
2023/20241.145 171 144 60 85 77 161 61 74 18 78 100 116
2024/20251.081 37 111 117 195 507 114 0 0 0 0 0 0
Totale 9.309